A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy

Table 2 Visual acuity and proptosis at 1-week after IVMP^a

Parameters	Total (n = 57 orbits)
(%)		p-value
BCVA, logMAR (mean ± SD)
Baseline	0.85 (0.63)	*< 0.001*
Post-treatment	0.63 (0.63)
Difference^b	0.21 (0.28)
Proptosis (mean ± SD)
Baseline	20.55 (3.18)	*< 0.001*
Post-treatment	18.75 (2.15)
Difference^b	1.8 (1.36)
Improvement in BCVA – no./total no.^c	29/57 (50.9)
Improvement in proptosis – no./total no.^c	13/57 (22.8)

^aAssessment of visual outcomes after 1 week of IVMP treatment. BCVA, best-corrected visual acuity; logMAR, logarithm of the minimum angle of resolution. Bold italicized text indicates statistical significance
^bAt baseline and at 1-week follow-up post-treatment, the mean difference between pre- and post-treatment values were calculated and reported as mean ± standard deviation
^cFavorable outcome was considered as ≥0.2 improvements in logMAR and reduction in proptosis of ≥2 mm after treatment, for visual acuity and proptosis, respectively

ISSN: 1471-2415